Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMC 238165)

Published in J Virol on December 01, 1993

Authors

C Bergmann1, M McMillan, S Stohlman

Author Affiliations

1: Department of Neurology, University of Southern California School of Medicine, Los Angeles.

Articles citing this

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18

Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol (1997) 1.54

Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection. J Virol (2003) 1.37

Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J Virol (1995) 1.34

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol (2004) 1.30

Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J Virol (1994) 1.20

Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol (1997) 1.14

Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J Virol (1993) 1.09

Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis. J Virol (2005) 1.04

NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis. J Virol (2007) 0.94

Predominance of MHC class II-restricted CD4+ cytotoxic T cells against mouse hepatitis virus A59. Immunology (1995) 0.89

Modulation of cellular macromolecular synthesis by coronavirus: implication for pathogenesis. J Virol (1994) 0.88

Antibody-mediated protection against cytotoxic T-cell escape in coronavirus-induced demyelination. J Virol (2003) 0.87

Gamma interferon signaling in oligodendrocytes is critical for protection from neurotropic coronavirus infection. J Virol (2009) 0.83

Specificity of the H-2 L(d)-restricted cytotoxic T-lymphocyte response to the mouse hepatitis virus nucleocapsid protein. J Virol (1996) 0.76

Distinct CD4 T cell effects on primary versus recall CD8 T cell responses during viral encephalomyelitis. Immunology (2014) 0.76

Articles cited by this

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (1991) 13.90

Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol (1989) 8.84

Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature (1990) 6.59

Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc Natl Acad Sci U S A (1989) 5.23

Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature (1991) 3.80

Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31

Coronavirus: organization, replication and expression of genome. Annu Rev Microbiol (1990) 3.20

Exact prediction of a natural T cell epitope. Eur J Immunol (1991) 2.90

Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J Virol (1989) 2.79

A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature (1989) 2.76

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells. Cell (1989) 2.31

Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. J Exp Med (1987) 2.28

Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11

Peptide selection by MHC class I molecules. Nature (1991) 2.01

Specific interaction between coronavirus leader RNA and nucleocapsid protein. J Virol (1988) 1.92

Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein. Virology (1990) 1.86

Coronavirus JHM: nucleotide sequence of the mRNA that encodes nucleocapsid protein. Nucleic Acids Res (1983) 1.82

Multi-pin peptide synthesis strategy for T cell determinant analysis. J Immunol Methods (1990) 1.78

Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol (1990) 1.70

Chronic central nervous system demyelination in mice after JHM virus infection. Neurology (1981) 1.57

Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex. J Exp Med (1992) 1.43

Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. Immunol Today (1991) 1.37

The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci (1993) 1.37

Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. J Immunol (1993) 1.24

In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J Immunol (1986) 1.17

Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide. Eur J Immunol (1991) 1.10

Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J Virol (1993) 1.09

Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J Neuroimmunol (1991) 1.07

Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. J Immunol (1992) 1.07

Mouse hepatitis virus nucleocapsid protein-specific cytotoxic T lymphocytes are Ld restricted and specific for the carboxy terminus. Virology (1992) 1.02

Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J Neuroimmunol (1991) 1.01

The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb Pathog (1987) 0.96

Sequence analysis and molecular detection of mouse hepatitis virus using the polymerase chain reaction. Lab Anim Sci (1992) 0.86

Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch Neurol (1987) 0.81

T cell-mediated clearance of JHMV from the central nervous system. Adv Exp Med Biol (1990) 0.78

Articles by these authors

Identification of the class I genes of the mouse major histocompatibility complex by DNA-mediated gene transfer. Nature (1982) 2.48

Gene transfer of H-2 class II genes: antigen presentation by mouse fibroblast and hamster B-cell lines. Cell (1984) 2.12

Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. Cell (1983) 1.86

Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer. Science (1982) 1.72

Structure of murine Ia antigens: partial NH2-terminal amino acid sequences of products of the I-E or I-C subregion. Proc Natl Acad Sci U S A (1977) 1.56

Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med (1992) 1.46

Expression of complete transplantation antigens by mammalian cells transformed with truncated class I genes. Nature (1983) 1.38

Structure of murine Ia antigens. Two dimensional electrophoretic analyses and high pressure liquid chromatography tryptic peptide maps of products of the I-A and I-E subregions and of an associated invariant polypeptide. J Exp Med (1981) 1.35

Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule. Proc Natl Acad Sci U S A (1988) 1.26

Expression of I-Ak class II genes in mouse L cells after DNA-mediated gene transfer. Nature (1983) 1.25

Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens. J Exp Med (1985) 1.23

Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J Exp Med (1990) 1.23

Identification of a unique tumor-specific antigen as a novel class I major histocompatibility molecule. Proc Natl Acad Sci U S A (1985) 1.23

An outbreak of suspected solanine poisoning in schoolboys: Examinations of criteria of solanine poisoning. Q J Med (1979) 1.21

Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J Virol (1994) 1.20

Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol (1995) 1.16

Chemical characterization of products of the H-2 complex. Cold Spring Harb Symp Quant Biol (1977) 1.11

Peptide map analyses of murine Ia antigens of the I-E subregion using HPLC. Nature (1979) 1.10

Cytotoxic T lymphocytes recognize determinants on the BALB/c-H-2Ld molecule controlled by alpha 1 and alpha 2 but not alpha 3 external domains. Immunogenetics (1984) 1.08

Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1989) 1.06

Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation. J Immunol (1994) 1.05

Isolation of the MHC genes encoding the tumour-specific class I antigens expressed on a murine fibrosarcoma. J Immunogenet (1987) 1.05

Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcaemia. Br Med J (1970) 1.02

T cell vaccination in secondary progressive multiple sclerosis. J Neuroimmunol (2000) 1.02

Preliminary observations on the effect of dietary brussels sprouts on thyroid function. Hum Toxicol (1986) 0.96

Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells. J Immunol (1985) 0.93

Evaluation of protocol using gene capture and PCR for detection of Helicobacter pylori DNA in feces. J Clin Microbiol (2003) 0.92

Molecular characterization of the C3HfB/HeN H-2Kkm2 mutation. Implications for the molecular basis of alloreactivity. J Exp Med (1988) 0.91

An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein. Eur J Immunol (1993) 0.89

Tuberculosis among foreign-born residents of southern Florida, 1995. Public Health Rep (1998) 0.88

Structures of four methyltetrazole-containing antiviral compounds in human rhinovirus serotype 14. Acta Crystallogr D Biol Crystallogr (1995) 0.87

The association of H-2Ld with human beta-2 microglobulin induces localized conformational changes in the alpha-1 and -2 superdomain. Immunogenetics (1989) 0.86

Contributions of [Ca2+]i, [Pi]i, and pHi to altered diastolic myocyte tone during partial metabolic inhibition. J Clin Invest (1991) 0.86

Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism. Acta Endocrinol (Copenh) (1970) 0.85

Release of a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase from cytotoxic T cells upon activation. J Immunol (1996) 0.85

Pulmonary involvement in Sweet's syndrome (acute febrile neutrophilic dermatosis). Preleukemic and leukemic phases of acute myelogenous leukemia. Chest (1986) 0.84

Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes. Circulation (1991) 0.83

Phosphorylation of the mouse hepatitis virus nucleocapsid protein. Biochem Biophys Res Commun (1986) 0.83

Functional characterization of the H-2Dp gene product. Immunogenetics (1984) 0.82

The ability of peptides to induce cytotoxic T cells in vitro does not strongly correlate with their affinity for the H-2Ld molecule: implications for vaccine design and immunotherapy. Mol Immunol (1997) 0.82

A comparison of the effect of two types of vibration exercise on the endocrine and musculoskeletal system. J Musculoskelet Neuronal Interact (2012) 0.82

Molecular characterization of novel H-2 class I molecules expressed by a C3H UV-induced fibrosarcoma. Proc Natl Acad Sci U S A (1985) 0.81

Disruption of the determinant hierarchy on a self-MHC peptide: concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant. Int Immunol (1994) 0.81

Measurement of potato steroidal alkaloids in human serum and saliva by radioimmunoassay. Hum Toxicol (1985) 0.81

Fine structure of an oat cell carcinoma of the lung associated with ectopic ACTH syndrome. Br J Cancer (1970) 0.80

Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis. Nat Med (1996) 0.80

Phorbol esters inhibit alpha 1-adrenergic receptor-stimulated phosphoinositide hydrolysis and contraction in rat aorta: evidence for a link between vascular contraction and phosphoinositide turnover. Biochem Biophys Res Commun (1986) 0.80

Effects of mouse hepatitis virus infection on host cell metabolism. Adv Exp Med Biol (1993) 0.80

Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology (1995) 0.80

Distinct epitopes are recognized by cytolytic T lymphocyte clones on the same class I molecule: direct demonstration using DNA-transfected targets and long-term cytolytic T cell clones. Eur J Immunol (1984) 0.79

Sclerosing peritonitis occurring in a hemodialysis patient. Am J Kidney Dis (1996) 0.78

Direct demonstration of critical amino acid residues required for cytotoxic T-lymphocyte allorecognition of H-2 class I antigens. Proc Natl Acad Sci U S A (1988) 0.78

Partial N-terminal amino acid sequences of guinea pig classic histocompatibility antigens. J Immunol (1980) 0.78

Tryptic peptide map analyses of mouse transplantation antigens. Immunogenetics (1981) 0.78

T cell-mediated clearance of JHMV from the central nervous system. Adv Exp Med Biol (1990) 0.78

ATP depletion causes a reversible decrease in Na+ pump density in cultured ventricular myocytes. Am J Physiol (1993) 0.78

Myelin proteolipid protein-induced Th1 and Th2 clones express TCR with similar fine specificity for peptide and CDR3 homology despite diverse V beta usage. Cell Immunol (1995) 0.77

Phosphatidyl inositol-linked forms of a murine class I MHC molecule expressed on Chinese hamster ovary cells retain peptide binding capability and alloreactivity. Int Immunol (1994) 0.77

Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12. J Neuroimmunol (1997) 0.77

Background paper. Advances in the study of MHV infection of mice. Adv Exp Med Biol (1990) 0.77

Cell-based gene therapy experiments in murine experimental autoimmune encephalomyelitis. Gene Ther (2005) 0.77

Single Dd amino acid substitutions in the H-2Ld molecule identify antibody epitopes. Immunogenetics (1994) 0.76

Plasma clearance and effects of alpha-hANP infused in patients with end-stage renal failure. Am J Physiol (1988) 0.76

Stability of four steroids in lyophilised human serum. Ann Clin Biochem (1983) 0.76

The role of peptide specificity in MHC class I-restricted allogeneic responses. Immunol Rev (1996) 0.76

Solanidine is present in sera of healthy individuals and in amounts dependent on their dietary potato consumption. Hum Toxicol (1985) 0.76

Using a defective-interfering RNA system to express the HE protein of mouse hepatitis virus for studying viral pathogenesis. Adv Exp Med Biol (1998) 0.76

Swearing: its prevalence in healthcare settings and impact on nursing practice. J Psychiatr Ment Health Nurs (2010) 0.76

Ultrastructural evidence of secretion in hormonally active oat-cell carcinomas: origin of one such tumour in the pancreas. J Clin Pathol (1971) 0.75

Hepatic alpha 1-adrenergic receptor alteration in a rat model of chronic sepsis. Circ Shock (1986) 0.75

Rethinking nursing. Collegian (1999) 0.75

Personality syles in the postoperative course. Psychosom Med (1973) 0.75

Setting the agenda for consumer-oriented care in the new millennium. Contemp Nurse (2001) 0.75

Condom use on campus. Fam Plann Perspect (1991) 0.75

Magnification renal arteriography. Br J Radiol (1979) 0.75

Molecular analysis of H-2 class I molecules expressed on the UV-induced tumour 1591. J Immunogenet (1990) 0.75

Genes of the major histocompatibility complex. Cold Spring Harb Symp Quant Biol (1983) 0.75

Effects of alloimmune injury on contraction and relaxation in cultured myocytes and intact cardiac allografts. J Am Coll Cardiol (1994) 0.75

Dissection of cross-reactivities using a panel of H-2Ld alloreactive T cell hybridomas. Cell Immunol (1995) 0.75

Changes in plasma atrial natriuretic factor during sequential fluid removal and biochemical correction in end-stage chronic renal failure patients. Nephron (1990) 0.75

Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus. Immunogenetics (1994) 0.75

Mass spectrometry measurement of a therapeutic peptide for use in multiple sclerosis. Gene Ther (2010) 0.75

Five cases of testicular feminisation including one with a teratoma of the testis. J Pathol Bacteriol (1966) 0.75

Modulation of mouse hepatitis virus infection by defective-interfering RNA-mediated expression of viral proteins and cytokines. J Neurovirol (1997) 0.75

H-2Ld-alloreactive T cell hybridomas utilize diverse V alpha and V beta T cell receptor chains. Mol Immunol (1996) 0.75

"An El Dorado of ease and elegance": taking the waters at White Sulphur Springs, 1866-1904. Montana (1985) 0.75

Potato steroidal alkaloids and neural tube defects: serum concentrations fail to demonstrate a causal relation. Hum Toxicol (1986) 0.75

Looking back: school nursing in England. Lamp (1980) 0.75

An ESR study of short-lived radicals derived from pyrimidines in aqueous solution. Biochim Biophys Acta (1969) 0.75

Assessing comprehensive nursing performance: the objective structured clinical assessment (OSCA). Part 2--Report of the evaluation project. Nurse Educ Today (1991) 0.75

Dissection of binding vs. recognition functions of H-2 class-I synthetic peptides which are recognized by alloreactive cytotoxic T lymphocytes. Int J Cancer Suppl (1991) 0.75

Assessing comprehensive nursing performance: the Objective Structural Clinical Assessment (OSCA). Part 1--Development of the assessment strategy. Nurse Educ Today (1991) 0.75

Evidence that derivation of the adenocarcinoma LT85 predated establishment of the H-2km2 mutation in a C3Hf colony of mice. J Immunogenet (1990) 0.75

All-trans retinoic acid affects the expression of orphan receptors COUP-TF I and COUP-TF II in the developing neural tube. Brain Res Dev Brain Res (1996) 0.75

Renal osteodystrophy: an underdiagnosed condition. Clin Radiol (1980) 0.75

Development of a filter paper blood spot radioimmunoassay for thyroid stimulating hormone suitable for a regional neonatal screening unit. Ann Clin Biochem (1983) 0.75

A question of advanced competence. Aust Nurs J (1996) 0.75

Letter: Thyrotrophin (T.S.H.) after iodine-131 therapy. Lancet (1974) 0.75